Title:
UTERINE TREATMENT COMPOSITION, UTERINE ENVIRONMENT-IMPROVING AGENT, IMPLANTATION AID, EMBRYO TRANSPLANTATION LIQUID, SPERM TRANSPLANTATION LIQUID, AND IMPLANTATION RATE-IMPROVING AGENT
Document Type and Number:
WIPO Patent Application WO/2024/095996
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide an excellent infertility treatment with which it is possible to increase the implantation rate of an embryo (fertilized egg) by improving the uterine environment. The present invention is a uterine treatment composition containing a mesenchymal stem cell culture supernatant, and is used as a uterine environment-improving agent, an implantation aid, an embryo transplant liquid, a sperm transplantation liquid, or an implantation rate-improving agent. The mesenchymal stem cells are preferably derived from adipose tissue, umbilical cord tissue, or bone marrow tissue.
Inventors:
SHIMADA MASAYUKI (JP)
UMEHARA TAKASHI (JP)
ISHIKAWA NORIYASU (JP)
TAKIJIRI TAKASHI (JP)
UMEHARA TAKASHI (JP)
ISHIKAWA NORIYASU (JP)
TAKIJIRI TAKASHI (JP)
Application Number:
PCT/JP2023/039207
Publication Date:
May 10, 2024
Filing Date:
October 31, 2023
Export Citation:
Assignee:
HIROSHIMA UNIV (JP)
ROHTO PHARMACEUTICAL CO LTD (JP)
ROHTO PHARMACEUTICAL CO LTD (JP)
International Classes:
C12N5/0775; A61K35/28; A61K35/35; A61K35/51; A61P15/00; A61P15/08
Attorney, Agent or Firm:
TSUKUNI & ASSOCIATES (5-3-1 Kojimachi, Chiyoda-k, Tokyo 83, JP)
Download PDF: